Are you Dr. Winston?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
# Ucha
Los Angeles, CA 90095Phone+1 310-825-6264Fax+1 310-206-5511
Summary
- Dr. Drew Winston, MD is an infectious disease specialist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Stewart & Lynda Resnick Neuropsychiatric Hospital at UCLA.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1976 - 1977- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1975 - 1976
University of Missouri-ColumbiaInternship, Internal Medicine, 1972 - 1973
University of Missouri-Columbia School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1977 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Start of enrollment: 2012 Oct 29
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
- Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 26 citationsIncreased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant RecipientsAlfonso Molina, Drew J. Winston, Darren Pan, Gary J. Schiller
Biology of Blood and Marrow Transplantation. 2018-08-01 - 60 citationsCytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection after Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F. Chemaly, Lynn El Haddad, Drew J. Winston, Scott D. Rowley, Kathleen M Mulane
Clinical Infectious Diseases. 2020-12-03 - 29 citationsControlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patientsDrew J. Winston, Winston G. Ho, David A. Bruckner, Gale Rp, Richard E. Champlin
The American Journal of Medicine. 1988-07-25
